BREAST CANCER TRIPLE NEGATIVE
Clinical trials for BREAST CANCER TRIPLE NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER TRIPLE NEGATIVE trials appear
Sign up with your email to follow new studies for BREAST CANCER TRIPLE NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation and immune drug combo aims to boost breast cancer treatment before chemo
Disease control Recruiting nowThis study is for people with stage 2 or 3 breast cancer. It tests whether giving a special type of radiation (SBRT) and an immunotherapy drug (pembrolizumab) directly into the tumor before standard chemotherapy can help shrink the cancer more effectively. The goal is to see if t…
Matched conditions: BREAST CANCER TRIPLE NEGATIVE
Phase: PHASE2 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
New study tracks immune signals in breast cancer patients
Knowledge-focused Recruiting nowThis study looks at how the immune system responds in people with early-stage triple negative breast cancer who are receiving standard chemotherapy combined with immunotherapy (pembrolizumab). Researchers will measure certain immune markers in blood and tissue samples to see if t…
Matched conditions: BREAST CANCER TRIPLE NEGATIVE
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 16, 2026 22:29 UTC